Probenecid
Top View
- Antigout Agents
- 1. Name of the Medicinal Product 2. Qualitative And
- PRODUCT INFORMATION PRO-CID™ (Probenecid Tablets
- Hyperuricemia and Dementia – a Case-Control Study Bettina Engel1,2, Willy Gomm3, Karl Broich4, Wolfgang Maier3,5, Klaus Weckbecker1 and Britta Haenisch3,4,6*
- Fenofibrate and Losartan That the Combination of Fenofibrate Or Losartan with Allopurinol Might Lower T Bardin the Hypouricaemic Effect of Allopurinol
- Altered Brain Penetration of Diclofenac and Mefenamic Acid, but Not Acetaminophen, in Shiga-Like Toxin II-Treated Mice
- Safety of Allopurinol Compared with Other Urate-Lowering Drugs in Patients with Gout: a Systematic Review and Meta-Analysis
- Xanthine Oxidase Inhibitor Step Therapy with Quantity Limit
- Krystexxa® (Pegloticase)
- Probenecid Tablets, USP
- Probenecid Tablets, USP500 Mgrx Only
- FDA Briefing Document
- Long Term Uricosuric T-Herapy in Gout
- Pyrazinamide (PZA)
- Probenecid, Nephrotic Syndrome, and Renal Failure by J
- Antihyperuricemics Review – March 2020 Page 2 | Proprietary Information
- Clinical Review Hyperuricemia and Gout
- Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor S